1)Nagashima Y, Kobayashi N, Kagawa E, et al:Chapter 2. Pathology and molecular biology of renal neoplasms:recent advances and impacts on pathological classification. In:Molecular Mechanism and Morphology in Cancer. edited by Nakamura M and Kakudo K. Bentham Science Publishers, Oak Park, pp12-38, 2009
2)日本泌尿器科学会,日本病理学会,日本放射線学会(編):腎癌取扱い規約(第4版),金原出版,東京,2011
3)Eble JN, Sauter G, Epstein JI, et al:World Health Organization classification of tumours:pathology & genetics tumours of the urinary system and male genital organs. IARC Press, Lyon, 2004
4)Fuhrman SA, Lasky LC and Limas C:Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655-663, 1982
5)Kondo K, Yao M, Yoshida M, et al:Comprehensive analysis of the VHL gene in sporadic renal cell carcinoma;relationship to clinico-pathological parameter. Genes Chromosomes Cancer 34:58-68, 2002
6)Maxwell PH:The HIF pathway in cancer. Semin Cell Dev Biol 16:523-530, 2005
7)Kuroda N, Ohe C, Mikami S, et al:Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 27:969-974, 2012
8)Delahunt B and Eble JN:Papillary renal cell carcinoma:a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10:537-544, 1997
9)Nagashima Y:Chromophobe renal cell carcinoma:clinical, pathological and molecular biological aspects. Pathol Int 50:872-878, 2000
10)黒田直人,長嶋洋治:色素嫌性腎細胞癌とオンコサイトーマ.病理と臨床28:1043-1047,2010
11)Tokuda N, Naito S, Matsuzaki O, et al:Collecting duct(Bellini duct)renal cell carcinoma:a nation-wide survey in Japan. J Urol 176:43-46, 2006
12)Kobayashi N, Matsuzaki O, Shirai S, et al:Collecting duct carcinoma of the kidney:an immunohistochemical evaluation of the use of antibodies for differential diagnosis. Hum Pathol 39:1350-1359, 2008
13)Kuroda N, Mikami S, Pann C-C, et al:Review of renal cell carcinoma associated with Xp11.2/TFE3 gene fusions with focus on pathbiological aspects. Histol Histopathol 27:133-140, 2012
14)Argani P, Lal P, Hutchinson B, et al:Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions:a sensitive and specific immunohistochemical assay. Am J Surg Pathol 27:750-761, 2003
15)Argani P, Olgac S, Tickoo SK, et al:Xp11 translocation renal cell carcinoma in adults:expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 31:1149-1160, 2007
16)Parwani AV, Husain AN, Epstein JI, et al:Low-grade myxoid renal epithelial neoplasms with distal nephron differentiation. Hum Pathol 32:506-512, 2001
17)Nouh MA, Kuroda N, Yamashita M, et al:Renal cell carcinoma in patients with end-stage renal disease:relationship between histological type and duration of dialysis. BJU Int 105:620-627, 2010